In PD, targeting HO-1 with ferroptosis inhibitors (such as ferrostatin-1 and liproxstatin-1), iron chelators, antioxidants, and Nrf2 inducers (like sulforaphane and curcumin) may protect dopaminergic neurons. This evidence concerns the gene HMOX1 and Parkinson disease.